The aberrant gut microbial community also increased susceptibility to colitis-associated cancer in NLRP6 inflammasome-deficient mice after AOM/DSS administration, showing the critical activity of NLRP6 for protection against inflammation-related colon tumorigenesis [44,48]. This evidence concerns the gene NLRP6 and cancer.